Cargando…

Sijunzi Decoction Targets IL1B and TNF to Reduce Neutrophil Extracellular Traps (NETs) in Ulcerative Colitis: Evidence from Silicon Prediction and Experiment Validation

PURPOSE: This study was conducted to explore the mechanism of Sijunzi Decoction (SJZ) in the treatment of ulcerative colitis (UC). METHODS: The study aimed to investigate the active components and targets of SJZ in the treatment of UC by screening databases such as TCMSP, GeneCards, OMIM, Distinct,...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Dong, Duan, Siwei, He, Zhangyou, Zhu, Zeming, Li, Zhiping, Yi, Qincheng, Cai, Tiantian, Li, Juanjuan, Chen, Nan, Guo, Shaoju
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10590142/
https://www.ncbi.nlm.nih.gov/pubmed/37868820
http://dx.doi.org/10.2147/DDDT.S428814
_version_ 1785123937186742272
author Zhang, Dong
Duan, Siwei
He, Zhangyou
Zhu, Zeming
Li, Zhiping
Yi, Qincheng
Cai, Tiantian
Li, Juanjuan
Chen, Nan
Guo, Shaoju
author_facet Zhang, Dong
Duan, Siwei
He, Zhangyou
Zhu, Zeming
Li, Zhiping
Yi, Qincheng
Cai, Tiantian
Li, Juanjuan
Chen, Nan
Guo, Shaoju
author_sort Zhang, Dong
collection PubMed
description PURPOSE: This study was conducted to explore the mechanism of Sijunzi Decoction (SJZ) in the treatment of ulcerative colitis (UC). METHODS: The study aimed to investigate the active components and targets of SJZ in the treatment of UC by screening databases such as TCMSP, GeneCards, OMIM, Distinct, TTD, and Drugbank. An online Venn tool, Cytoscape 3.7.2, and Autodock Tools were used to analyze the components and targets. The study also used a mouse model of UC to further investigate the effects of SJZ. HE staining, immunofluorescence, ELISA, qPCR, and Western blot were used to detect various indices. RESULTS: Eighty-three active components and 112 action targets were identified from SJZ, including 67 targets for treating UC-related NETs. The five core targets identified were AKT1, JUN, IL1B, PTGS2, and TNF, and molecular docking studies indicated that the five targets were well-docked with ginsenoside Rh2, isoflavones, and formononetin. Animal experiments demonstrated that SJZ could alleviate various parameters such as weight, colon length, spleen index, disease activity index, and intestinal pathology of the UC mice. Immunofluorescence and Western blot showed that SJZ could reduce the expression of IL1B and TNF in intestinal neutrophils while increasing the expression of Occludin. Cellular immunofluorescence suggests that SJZ can reduce the expression of TNF and IL1B in NETs. The qPCR results also suggested that SJZ could inhibit TNF signal. Furthermore, ELISA results suggested that SJZ could inhibit the expression of pro-inflammatory cytokines (TNF-α, IL-1β, IL-6) while promoting the expression of anti-inflammatory cytokines (IL-10, IL-37, TGF-β). CONCLUSION: SJZ treats UC by reducing the content of intestinal NETs, with primary targets on the NETs being IL1B and TNFand suppress TNF signal. The practical components of SJZ may be ginsenoside Rh2, isoflavones, and formononetin.
format Online
Article
Text
id pubmed-10590142
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-105901422023-10-22 Sijunzi Decoction Targets IL1B and TNF to Reduce Neutrophil Extracellular Traps (NETs) in Ulcerative Colitis: Evidence from Silicon Prediction and Experiment Validation Zhang, Dong Duan, Siwei He, Zhangyou Zhu, Zeming Li, Zhiping Yi, Qincheng Cai, Tiantian Li, Juanjuan Chen, Nan Guo, Shaoju Drug Des Devel Ther Original Research PURPOSE: This study was conducted to explore the mechanism of Sijunzi Decoction (SJZ) in the treatment of ulcerative colitis (UC). METHODS: The study aimed to investigate the active components and targets of SJZ in the treatment of UC by screening databases such as TCMSP, GeneCards, OMIM, Distinct, TTD, and Drugbank. An online Venn tool, Cytoscape 3.7.2, and Autodock Tools were used to analyze the components and targets. The study also used a mouse model of UC to further investigate the effects of SJZ. HE staining, immunofluorescence, ELISA, qPCR, and Western blot were used to detect various indices. RESULTS: Eighty-three active components and 112 action targets were identified from SJZ, including 67 targets for treating UC-related NETs. The five core targets identified were AKT1, JUN, IL1B, PTGS2, and TNF, and molecular docking studies indicated that the five targets were well-docked with ginsenoside Rh2, isoflavones, and formononetin. Animal experiments demonstrated that SJZ could alleviate various parameters such as weight, colon length, spleen index, disease activity index, and intestinal pathology of the UC mice. Immunofluorescence and Western blot showed that SJZ could reduce the expression of IL1B and TNF in intestinal neutrophils while increasing the expression of Occludin. Cellular immunofluorescence suggests that SJZ can reduce the expression of TNF and IL1B in NETs. The qPCR results also suggested that SJZ could inhibit TNF signal. Furthermore, ELISA results suggested that SJZ could inhibit the expression of pro-inflammatory cytokines (TNF-α, IL-1β, IL-6) while promoting the expression of anti-inflammatory cytokines (IL-10, IL-37, TGF-β). CONCLUSION: SJZ treats UC by reducing the content of intestinal NETs, with primary targets on the NETs being IL1B and TNFand suppress TNF signal. The practical components of SJZ may be ginsenoside Rh2, isoflavones, and formononetin. Dove 2023-10-17 /pmc/articles/PMC10590142/ /pubmed/37868820 http://dx.doi.org/10.2147/DDDT.S428814 Text en © 2023 Zhang et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Zhang, Dong
Duan, Siwei
He, Zhangyou
Zhu, Zeming
Li, Zhiping
Yi, Qincheng
Cai, Tiantian
Li, Juanjuan
Chen, Nan
Guo, Shaoju
Sijunzi Decoction Targets IL1B and TNF to Reduce Neutrophil Extracellular Traps (NETs) in Ulcerative Colitis: Evidence from Silicon Prediction and Experiment Validation
title Sijunzi Decoction Targets IL1B and TNF to Reduce Neutrophil Extracellular Traps (NETs) in Ulcerative Colitis: Evidence from Silicon Prediction and Experiment Validation
title_full Sijunzi Decoction Targets IL1B and TNF to Reduce Neutrophil Extracellular Traps (NETs) in Ulcerative Colitis: Evidence from Silicon Prediction and Experiment Validation
title_fullStr Sijunzi Decoction Targets IL1B and TNF to Reduce Neutrophil Extracellular Traps (NETs) in Ulcerative Colitis: Evidence from Silicon Prediction and Experiment Validation
title_full_unstemmed Sijunzi Decoction Targets IL1B and TNF to Reduce Neutrophil Extracellular Traps (NETs) in Ulcerative Colitis: Evidence from Silicon Prediction and Experiment Validation
title_short Sijunzi Decoction Targets IL1B and TNF to Reduce Neutrophil Extracellular Traps (NETs) in Ulcerative Colitis: Evidence from Silicon Prediction and Experiment Validation
title_sort sijunzi decoction targets il1b and tnf to reduce neutrophil extracellular traps (nets) in ulcerative colitis: evidence from silicon prediction and experiment validation
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10590142/
https://www.ncbi.nlm.nih.gov/pubmed/37868820
http://dx.doi.org/10.2147/DDDT.S428814
work_keys_str_mv AT zhangdong sijunzidecoctiontargetsil1bandtnftoreduceneutrophilextracellulartrapsnetsinulcerativecolitisevidencefromsiliconpredictionandexperimentvalidation
AT duansiwei sijunzidecoctiontargetsil1bandtnftoreduceneutrophilextracellulartrapsnetsinulcerativecolitisevidencefromsiliconpredictionandexperimentvalidation
AT hezhangyou sijunzidecoctiontargetsil1bandtnftoreduceneutrophilextracellulartrapsnetsinulcerativecolitisevidencefromsiliconpredictionandexperimentvalidation
AT zhuzeming sijunzidecoctiontargetsil1bandtnftoreduceneutrophilextracellulartrapsnetsinulcerativecolitisevidencefromsiliconpredictionandexperimentvalidation
AT lizhiping sijunzidecoctiontargetsil1bandtnftoreduceneutrophilextracellulartrapsnetsinulcerativecolitisevidencefromsiliconpredictionandexperimentvalidation
AT yiqincheng sijunzidecoctiontargetsil1bandtnftoreduceneutrophilextracellulartrapsnetsinulcerativecolitisevidencefromsiliconpredictionandexperimentvalidation
AT caitiantian sijunzidecoctiontargetsil1bandtnftoreduceneutrophilextracellulartrapsnetsinulcerativecolitisevidencefromsiliconpredictionandexperimentvalidation
AT lijuanjuan sijunzidecoctiontargetsil1bandtnftoreduceneutrophilextracellulartrapsnetsinulcerativecolitisevidencefromsiliconpredictionandexperimentvalidation
AT chennan sijunzidecoctiontargetsil1bandtnftoreduceneutrophilextracellulartrapsnetsinulcerativecolitisevidencefromsiliconpredictionandexperimentvalidation
AT guoshaoju sijunzidecoctiontargetsil1bandtnftoreduceneutrophilextracellulartrapsnetsinulcerativecolitisevidencefromsiliconpredictionandexperimentvalidation